sugar and semaglutide for Type-2 Diabetes vs. Weight Loss: Understanding the Difference Study Displays the Benefits of

You should generally not stop your medication unless specifically instructed by a healthcare provider

Key takeaways Mounjaro (tirzepatide) is FDA approved for Type 2 diabetes but is often prescribed off-label for weight loss

Prior to initiation, train patients and their caregiver(s) on proper injection technique for the prescribed WEGOVY presentation [see Instructions for Use]

FLS contributed with study conception, study design, data analysis, data interpretation, critical manuscript revision and final manuscript approval

Zydus Lifesciences has launched its semaglutide injection in India under the brand names SEMAGLYN, MASHEMA and ALTERME, following patent expiry